ESC Premium Access

LDL-C reducing agents; what genetic tells us

Congress Presentation

About the speaker

Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)
31 presentations

3 more presentations in this session

To be or not to be…but at which goal?

Speaker: Professor L. Tokgozoglu (Ankara, TR)


Combination therapy in CV risk reduction: what are we waiting for in dyslipidaemia management?

Speaker: Professor P. Steg (Paris, FR)


Getting to goals cost effectively, how can we make a difference?

Speaker: Professor E. Stroes (Amsterdam, NL)


Access the full session

Hypercholesterolemia management - What will be our options after tomorrow?

Speakers: Professor B. Ference, Professor L. Tokgozoglu, Professor P. Steg, Professor E. Stroes

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb